Objectif
This research addresses a clinical problem with an innovative approach. Pancreatic cancer is one of the deadliest cancers and only 10% of patients survive 5 years after diagnosis. To find better therapies, we need patient-specific models that mimic the biology of tumour tissues and target interactions between different cell types. We will develop a controllable platform for modelling the human disease in the laboratory. We will use our new platform to discover better ways of treating the disease.
Champ scientifique
Mots‑clés
Programme(s)
- HORIZON.1.1 - European Research Council (ERC) Main Programme
Régime de financement
HORIZON-ERC-POC - HORIZON ERC Proof of Concept GrantsInstitution d’accueil
LEIBNIZ-INSTITUT FUR POLYMERFORSCHUNG DRESDEN EV
Contribution nette de l'UE
€ 150 000,00
Adresse
HOHE STRASSE 6
01069 Dresden
Allemagne
01069 Dresden
Allemagne
Région
Sachsen
Dresden
Dresden, Kreisfreie Stadt
Type d’activité
Research Organisations
Liens
Coût total
Aucune donnée